Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 06, 2020

SELL
$8.05 - $14.21 $104,891 - $185,156
-13,030 Closed
0 $0
Q1 2020

May 11, 2020

BUY
$6.8 - $14.66 $17,068 - $36,796
2,510 Added 23.86%
13,030 $119,000
Q4 2019

Feb 05, 2020

BUY
$12.82 - $16.85 $54,664 - $71,848
4,264 Added 68.16%
10,520 $141,000
Q3 2019

Nov 12, 2019

BUY
$16.31 - $28.29 $16,554 - $28,714
1,015 Added 19.37%
6,256 $108,000
Q2 2019

Aug 08, 2019

SELL
$19.18 - $27.88 $152,154 - $221,172
-7,933 Reduced 60.22%
5,241 $143,000
Q1 2019

Apr 26, 2019

BUY
$8.0 - $19.66 $14,352 - $35,270
1,794 Added 15.76%
13,174 $252,000
Q4 2018

Feb 08, 2019

BUY
$8.59 - $18.05 $39,161 - $82,289
4,559 Added 66.84%
11,380 $101,000
Q3 2018

Nov 13, 2018

BUY
$17.11 - $21.74 $116,707 - $148,288
6,821 New
6,821 $129,000

Others Institutions Holding VYGR

About Voyager Therapeutics, Inc.


  • Ticker VYGR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,647,600
  • Market Cap $206M
  • Description
  • Voyager Therapeutics, Inc., a gene therapy company, focuses on the development of treatments and next-generation platform technologies. The company's lead clinical candidate is the VY-AADC, which is in open-label Phase 1 clinical trial for the treatment of Parkinson's disease. Its preclinical programs comprise VY-SOD102 for the treatment of amyo...
More about VYGR
Track This Portfolio

Track Mitsubishi Ufj Kokusai Asset Management Co., Ltd. Portfolio

Follow Mitsubishi Ufj Kokusai Asset Management Co., Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mitsubishi Ufj Kokusai Asset Management Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mitsubishi Ufj Kokusai Asset Management Co., Ltd. with notifications on news.